Llwytho...
Putting a Lid on Chemotherapy Costs
Genomic Health’s Oncotype DX Colon Cancer Assay assesses the risk of stage II colon cancer recurrence and potential adjuvant chemotherapy benefit. Cost savings could be huge.
Wedi'i Gadw mewn:
| Prif Awdur: | |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BioCommunications LLC
2011
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3138387/ https://ncbi.nlm.nih.gov/pubmed/22478853 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|